Design, synthesis and pharmacological evaluation of new 2-oxo-quinoline derivatives containing α-aminophosphonates as potential antitumor agents. 2017

Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
College of Pharmacy , Guilin Medical University , Guilin 541004 , PR China . Email: zhangye81@126.com ; Email: mxl78@glmc.edu.cn ; ; Tel: +86 773 5895132.

A series of novel 2-oxo-quinoline derivatives containing α-aminophosphonates were designed and synthesized as antitumor agents. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay results demonstrated that some compounds exhibited moderate to high inhibitory activity against HepG2, SK-OV-3 and NCI-H460 tumor cell lines, and most compounds showed much lower cytotoxicity against HL-7702 normal cells than 5-FU and cisplatin. The action mechanism of representative compound 5b was investigated by fluorescence staining assay, flow cytometric analysis and western blot (WB) assay, which indicated that this compound induced apoptosis and G2/M phase arrest accompanied by an increase in the production of intracellular Ca2+ and reactive oxygen species (ROS) and affecting associated enzymes and genes.

UI MeSH Term Description Entries

Related Publications

Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
September 2019, European journal of medicinal chemistry,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
July 2019, Archiv der Pharmazie,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
September 2018, European journal of medicinal chemistry,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
December 2021, Acta pharmaceutica (Zagreb, Croatia),
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
December 2014, Bioorganic chemistry,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
January 2019, European journal of medicinal chemistry,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
July 2016, Molecules (Basel, Switzerland),
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
October 2010, Archiv der Pharmazie,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
October 2007, Journal of medicinal chemistry,
Yan-Cheng Yu, and Wen-Bin Kuang, and Ri-Zhen Huang, and Yi-Lin Fang, and Ye Zhang, and Zhen-Feng Chen, and Xian-Li Ma
July 2018, RSC advances,
Copied contents to your clipboard!